WHO ICTRP trial

The application of TRUS-MRI real-time three dimensional image fusion prostate…

ChiCTR1800017443 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR1800017443
Public title The application of TRUS-MRI real-time three dimensional image fusion prostate biopsy system based on novel intracavitary registration device
Scientific title The application of TRUS-MRI real-time three dimensional image fusion prostate biopsy system based on novel intracavitary registration device
Primary sponsor Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Diagnostic test
Phase Diagnostic New Technique Clincal Study
Countries China
Conditions Prostate cancer
Interventions Gold Standard:Prostate biopsy pathology or radical prostatectomy pathology;Index test:TRUS-MRI real-time three dimensional image fusion prostate biopsy based on novel intracavitary registration device
Registration date Jul 30, 2018
Target size Target condition:40;Difficult condition:0
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations